Advertisement

Topics

Latest "Goldman , Sachs & Co." News Stories

04:15 EST 16th December 2017 | BioPortfolio

Here are the most relevant search results for "Goldman , Sachs & Co." found in our extensive news archives from over 250 global news sources.

More Information about Goldman , Sachs & Co. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Goldman , Sachs & Co. for you to read. Along with our medical data and news we also list Goldman , Sachs & Co. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Goldman , Sachs & Co. Companies for you to search.

Showing "Goldman Sachs" News Articles 1–25 of 286

Friday 15th December 2017

Amgen-Aktie büßt Attraktivität ein! - Aktienanalyse

New York - Amgen-Aktienanalyse der Analystin Jami Rubin von Goldman Sachs: Jami Rubin, Aktienanalystin bei Goldman Sachs, spricht laut einer Aktienanalyse eine Kaufempfehlung für die Aktien des Bio...


ANALYSE-FLASH: Goldman hebt Teva auf 'Buy' und Ziel hoch 20 US-Dollar

NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat Teva von "Neutral" auf "Buy" hochgestuft und das Kursziel von 15 auf 20 US-Dollar angehoben. Mit der Ankündigung von Kostensenku...

TEVA Pharmaceuticals-Aktie erhält Ritterschlag - Aktienanalyse

New York - TEVA Pharmaceuticals-Aktienanalyse der Analystin Jami Rubin von Goldman Sachs: Aktienanalystin Jami Rubin von der Investmentbank Goldman Sachs spricht laut einer aktuellen Aktienanalyse ...


Wednesday 13th December 2017

”Mainstream Mental Health Radio” Seeking Today’s Top Psychologists & Personal Development Experts

“Mainstream Mental Health Radio,” a program (part of Mental Health News Radio Network) hosted by Dr. John Huber is seeking to feature today’s top psychologists & personal development experts as guests. AUSTIN, Texas (PRWEB) December 13, 2017 “Mainstream Mental Health Radio,” a program (part of Mental Health News Radio Network) hosted by Dr. John Huber is seeking to feature today’s...

Goldman Sachs Aktie: Kaufen - Mustergültiger Ausbruch aus dem Seitwärtstrend!

Chartanalyse der Goldman Sachs - Aktie Die Goldman Sachs Aktie befand sich in einem intakten langfristigen Seitwärtstrendkanal. Am 12.12.2017 hat die Aktie den Bereich dieser Seitwärtsbewegung nac...

Tuesday 12th December 2017

Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock

Goldman Sachs & Co. LLC, Morgan Stanley and Cowen are acting as joint book-running managers for the offering. Canaccord Genuity is acting as co-manager for the Read more...

Crypto Report: Goldman Sachs sieht kein Risiko für Gold durch Bitcoin

shareribs.com - Der Goldpreis ist in den vergangenen Wochen unter Druck geraten. Während der festere Dollar und steigende Zinsen den Preis belasten, sehen einige auch die steigende Nachfrage nach B...

Crytpo Report: Goldman Sachs sieht kein Risiko für Gold durch Bitcoin

shareribs.com - Der Goldpreis ist in den vergangenen Wochen unter Druck geraten. Während der festere Dollar und steigende Zinsen den Preis belasten, sehen einige auch die steigende Nachfrage nach B...

FTSE 250 movers: Elementis rallies on sale; Saga hit by Goldman downgrade

London's FTSE 250 was flat at 20,058.97 in afternoon trade on Tuesday. Elementis was the best performer as the speciality chemicals company said it has agreed to sell its Netherlands surfactants bu...

McDonald's-Aktie: neues Value-Menü sorgt für Spitzenplatz! - Aktienanalyse

New York - McDonald's-Aktienanalyse von Analystin Karen Holthouse von Goldman Sachs: Karen Holthouse, Aktienanalystin von Goldman Sachs, empfiehlt die Aktien von McDonald's Corp. (ISIN: US580135101...

Correction of a release from 11.12.2017, 10:40 CET/CEST - Evotec AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Evotec AG 12.12.2017 / 13:37 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Evotec AG Manfred Eigen Campus / Essener Bogen 7 22419 Hamburg Germany 2. Reason for notification  

Monday 11th December 2017

Odonate Therapeutics Announces Closing of Initial Public Offering

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced the closing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $24.00 per share. The aggregate gross proceeds f...

Revance Announces Closing of Public Offering of Common Stock

Gross Proceeds of Offering Total $167.1 Million Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions (“Revance” or the “Company”), today announced the closing of an underwritten public offering of 6,139,515 shares of its common stock at a ...

Evotec AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Evotec AG 11.12.2017 / 10:40 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Evotec AG Manfred Eigen Campus / Essener Bogen 7 22419 Hamburg Germany 2. Reason for notification  

Sunday 10th December 2017

Daimler-Aktie: Sollten Anleger der Empfehlung von Goldman Sachs folgen?

Liebe Leser, Goldman Sachs hat in einer neuen Studie die Daimler-Aktie genauer unter die Lupe genommen. Das bisherige Kursziel lag bei 84 Euro und damit schon recht deutlich über dem aktuellen Kurs...

Thursday 7th December 2017

Kathy Ireland Contributes $100,000 World Aids Day Gift To The Elizabeth Taylor AIDS Foundation Announces Level Brands Inc.

Ireland states gesture seeks to "continue the ardor with which a great actress and humanitarian led the fight against this still-deadly disease" (PRWEB) December 07, 2017 To call attention to the continuing urgency of the battle to address and conquer HIV/AIDS, Level Brands, Inc. has announced that its Chairman Emeritus and Chief Brand Strategist, Kathy Ireland--also chair of kathy irel...

Revance Announces Pricing of Public Offering of Common Stock

Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions (“Revance” or the “Company”), today announced the pricing of an underwritten public offering of 5,338,709 shares of its common stock at a price to the public of $31.00 per share. In the offe...

Wednesday 6th December 2017

Odonate Therapeutics Announces Pricing of Initial Public Offering

Odonate Therapeutics, Inc. (the Company or Odonate), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $24.00 per share for aggregate gross ...

Novo Nordisk: Ein Verkaufserfolg

Die Analysten von Goldman Sachs bestätigen die Kaufempfehlung für die Aktien von Novo Nordisk. Das Kursziel für die Papiere der Dänen sehen die Experten weiter bei 345,00 DKK. Die Zulassung von Sem...

Tuesday 5th December 2017

Revance Announces Proposed Public Offering of Common Stock

Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions (“Revance” or the “Company”), today announced a proposed underwritten public offering in which it will issue and sell approximately $175 million of shares of its common stock. In addition, ce...

Friday 1st December 2017

Goldman belässt GlaxoSmithKline auf 'Buy' - Ziel 1775 Pence

Die US-Investmentbank Goldman Sachs hat die Einstufung für GlaxoSmithKline nach einem Kapitalmarkttag für die "Consumer Health"-Sparte auf "Buy" mit einem Kursziel von 1775 Pence belassen. Dass si...

Thursday 30th November 2017

Chef von Goldman Sachs hält nicht viel vom Bitcoin

NEW YORK (dpa-AFX) - Der Chef der US-Investmentbank Goldman Sachs , Lloyd Blankfein, sieht noch keinen Bedarf für eine Strategie im Umgang mit der Digitalwährung Bitcoin. "Etwas, das sich an einem...

Marcus by Goldman Sachs introduces game-changing new lending platform to consumers

Whether you’re eighteen or eighty-three, you’ve probably come to the realization that sometimes things in life just, well, happen.

Wednesday 29th November 2017

Zions Bancorporation To Present At The Goldman Sachs U.S. Financial Services Conference 2017

Zions Bancorporation To Present At The Goldman Sachs U.S. Financial Services Conference 2017 Read more...

Huntington Bancshares To Present At The Goldman Sachs U.S. Financial Services Conference

Webcast Information  Interested investors may access the live audio presentation in the investor relations section of Huntington's website ( www.huntington.com).  A replay of the Read more...


Quick Search
Advertisement
 

News Quicklinks